1. Home
  2. CCM vs XCUR Comparison

CCM vs XCUR Comparison

Compare CCM & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concord Medical Services Holdings Limited

CCM

Concord Medical Services Holdings Limited

N/A

Current Price

$4.52

Market Cap

23.8M

Sector

Health Care

ML Signal

N/A

XCUR

Exicure Inc.

HOLD

Current Price

$5.88

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCM
XCUR
Founded
1997
2011
Country
China
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.8M
26.6M
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
CCM
XCUR
Price
$4.52
$5.88
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1K
1.7M
Earning Date
09-26-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$51,056,841.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$3.10
52 Week High
$10.77
$15.91

Technical Indicators

Market Signals
Indicator
CCM
XCUR
Relative Strength Index (RSI) 54.29 54.17
Support Level $3.60 $5.31
Resistance Level $5.72 $6.04
Average True Range (ATR) 0.45 0.34
MACD 0.10 -0.05
Stochastic Oscillator 41.97 45.57

Price Performance

Historical Comparison
CCM
XCUR

About CCM Concord Medical Services Holdings Limited

Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Share on Social Networks: